Some visit links earn us a commission.

Wegovy vs Mounjaro cost: $349 vs $499 a month

Prices checked November 16, 2026

Paying cash from the makers on November 16, 2026, Wegovy (semaglutide, for weight loss) is $349 a month at NovoCare and Mounjaro (tirzepatide, for type 2 diabetes) is $499 a month at every dose at LillyDirect. Mounjaro is not approved for weight loss, so a plan that pays for it usually needs a type 2 diabetes diagnosis; the same medicine approved for weight loss is Zepbound, from $299.

No insurance needed. Two programs to check.

These two get compared because both took off a lot of weight in clinical trials. They answer different questions at the pharmacy, though: one is a weight loss drug and the other a diabetes drug, and that decides who pays.

Wegovy vs Mounjaro, side by side

Wegovy and Mounjaro compared on medicine, approval, cash price, savings card, Medicare and doses
WegovyMounjaro
Medicine
SemaglutideTirzepatide
Sold for cash by
NovoCare (Novo Nordisk)LillyDirect (Eli Lilly)
Approved for
Weight loss. Also lowers heart risk in people with heart disease, and treats a fatty liver disease (MASH)Type 2 diabetes, in adults and children 10 and older. Also lowers the risk of heart attack and stroke in adults with type 2 diabetes who are at high risk
Cash price
$349 a month for the pen and $399 for the 7.2 mg HD pen$499 a month
Form sold for cash
The Wegovy pen, or the 7.2 mg HD penThe single-dose pen
List price before insurance
$1,349.02 a fill$1,112.16 a fill
Savings card, with commercial insurance
As low as $25/mo (max $100/mo off)As low as $25 for up to a 3-month Rx (annual max $1,950), until December 31, 2026
Medicare GLP-1 Bridge
$50 a monthNot included
Doses
1.7 mg or 2.4 mg, with 2.4 mg marked recommended. Highest dose 7.2 mg weeklyNo set maintenance dose. Highest dose 15 mg in adults

Cash prices are NovoCare's and LillyDirect's own, checked November 16, 2026. You need a prescription for either.

What each costs without insurance

NovoCare sells the Wegovy pen at $349 a month from 0.25 mg to 2.4 mg and the 7.2 mg HD pen at $399. LillyDirect sells Mounjaro at $499 a month for the single-dose pen at every dose, for 28 days, up to 4 single-dose pens.

That puts Mounjaro $150 a month above the regular Wegovy pen. Full lists by dose: Wegovy cost and Mounjaro cost.

For weight loss, compare Zepbound

Mounjaro's label covers type 2 diabetes only. Its medicine, tirzepatide, is sold for weight loss as Zepbound, at $299 at 2.5 mg, $399 at 5 mg and $449 to $699 at 7.5 mg and up at LillyDirect. Someone choosing a weight loss drug is really choosing between Wegovy and Zepbound: Wegovy vs Zepbound.

In SURMOUNT-5, the one head-to-head weight loss trial, tirzepatide took off 20.2 percent of body weight on average and semaglutide 13.7 percent over 72 weeks. Why one medicine carries two names: Mounjaro vs Zepbound.

Who pays for which

A plan pays for Mounjaro when you have type 2 diabetes, often after prior approval. Without diabetes, a Mounjaro prescription for weight loss is off-label and plans rarely cover it.

A plan pays for Wegovy only where it covers weight loss, or for its heart and fatty liver uses. Prior approval is common.

Both makers have a savings card for people with commercial insurance that covers the drug. Wegovy's terms read as low as $25/mo (max $100/mo off). Mounjaro's read as low as $25 for up to a 3-month Rx (annual max $1,950), until December 31, 2026. Neither works with Medicare or Medicaid.

Medicare

The Medicare GLP-1 Bridge charges $50 a month for Wegovy to Part D members who qualify, from July 1, 2026 to December 31, 2027. Mounjaro is not on the Bridge list, and people with type 2 diabetes are outside the Bridge. Medicare says their Part D plan might cover the drug instead.

From January 1, 2027, Wegovy gets a $274 Medicare negotiated price for a 30-day supply. That is the plan's price, not your copay.

Questions people ask

Is Wegovy cheaper than Mounjaro?
Paying cash, yes. Wegovy is $349 a month at NovoCare and Mounjaro $499 at every dose at LillyDirect. With insurance, the diagnosis decides which one a plan covers.
Can I take Mounjaro for weight loss?
Mounjaro is approved for type 2 diabetes. The same medicine is approved for weight loss as Zepbound, which LillyDirect sells from $299 a month.
Are Wegovy and Mounjaro the same drug?
No. Wegovy is semaglutide from Novo Nordisk. Mounjaro is tirzepatide from Eli Lilly, which acts on a second gut hormone, GIP.
Does Medicare cover Wegovy or Mounjaro?
A Part D plan might cover Mounjaro for type 2 diabetes. The Medicare GLP-1 Bridge charges $50 a month for Wegovy to members who qualify.

Compare other GLP-1 medications

Sources

Evidence checked November 15, 2026

Every figure above is taken from the document beside it, the FDA label or the trial that produced it, so you can read the source instead of trusting us. How we check sources.

7 documents

  1. What Wegovy is approved for and its dosesFDA prescribing information for Wegovy, injection and tablets (DailyMed, revised June 2026)
  2. What Mounjaro is approved for and its dosesFDA prescribing information for Mounjaro (DailyMed, revised August 2026)
  3. SURMOUNT-5: tirzepatide against semaglutide in 751 adults with obesity and no type 2 diabetes, 20.2 percent against 13.7 percent of body weight at 72 weeksAronne LJ et al. N Engl J Med 2025;393(1):26-36 (PubMed 40353578)
  4. Mounjaro's list price for one fill, before insurance or discountsMounjaro cost information (Eli Lilly)
  5. Which GLP-1 drugs the Medicare GLP-1 Bridge covers, who qualifies and who is outside itWeight loss drugs (Medicare.gov)
  6. The Bridge's $50 copay and its dates, July 1, 2026 to December 31, 2027Medicare GLP-1 Bridge (CMS)
  7. Wegovy's $274 Medicare negotiated price for a 30-day supply from January 1, 2027CMS fact sheet on 2027 negotiated prices

Prices from NovoCare, LillyDirect and the makers' savings card and list price pages, checked November 16. How we check prices.